Objectives: Many people living with HIV/AIDS in resource-limited settings begin antiretroviral therapy (ART) at low CD4 counts. Here, we investigated the simultaneous effect of individual-, facility-and regional-level factors on late ART initiation.
Introduction
Sub-Saharan Africa remains the region most affected by the HIV pandemic, with an estimated 22.5 million people living with HIV/ AIDS (PLWHA) in 2009, representing 68% of the global HIVrelated disease burden. 1 Massive increases in global funding for HIV/AIDS over the past decade have enabled a rapid scale-up of antiretroviral therapy (ART) in settings most affected by HIV. 2, 3 In sub-Saharan Africa, the number of PLWHA on ART increased from 800 000 in 2005 to 5.1 million by the end of 2010. 4 However, a large proportion of adults begin ART at CD4 cell counts far below those recommended in national guidelines for resource-limited settings. 5 -7 The timing of ART initiation is a major determinant of the capacity for immune reconstitution. Late ART initiation is associated with poorer responses to treatment 8 -10 and with higher morbidity and mortality. 11, 12 Early ART initiation improves the survival and quality of life of HIV-infected individuals and also affords more rapid viral load suppression, which lowers the risk of HIV transmission. 13 -15 It is crucial to understand the reasons for delays in medical care for HIV infection if the public health authorities are to overcome barriers to timely management. 16 -18 With an estimated HIV seroprevalence of 4.3%, Cameroon is among the most affected countries in central Africa. 19 The estimated number of PLWHA receiving ART rose from 17000 in 2005 to 89 000 by the end of 2010, 20 when 38% of ART-eligible indivi-duals were on treatment. 4 This rapid increase in ART access has been due to the availability of free ART in Cameroon since May 2007. However, ART is still generally started at low CD4 cell counts (median 124/mm 3 ) in Cameroon. 21 Various factors may play a role in late ART initiation, including not only individual characteristics and HIV-testing behaviours, but also healthcare access and the social environment. 22 -24 Past studies have focused on risk factors for late ART initiation either at the individual level, at the individual level and facility level or at the facility level and regional level. 7,25 -28 The objective of this study was to investigate the simultaneous effect of individual-, facility-and regional-level factors associated with late ART initiation in an HIV treatment programme in Cameroon.
Methods

HIV care and ART delivery
Before August 2010, Cameroonian national guidelines recommended ART initiation for all patients with CD4 ≤200 cells/mm 3 and/or advanced clinical disease. 29 In August 2010, Cameroon adopted the 2010 WHO guidelines, which recommend ART initiation at CD4 ≤350 cells/mm 3 . 30 In late 2010, ART in Cameroon was delivered through 145 HIV treatment facilities, including 24 accredited treatment centres (ATCs) located in central and regional hospitals and also 121 district HIV management units (MUs) integrated in district-level hospitals located mainly in small towns and rural areas. Central and regional hospitals are larger and better equipped than district-level hospitals. 31 All ATCs, but only some MUs, are equipped with a CD4 machine to perform immunological tests and also carry out biological tests associated with HIV management. MUs provide only first-line ART regimens and normally refer complicated HIV cases and patients who require second-line regimens to their mentor ATCs, which are reference centres for ART.
Study design
With the approval of the Cameroonian Ministry of Public Health and National Ethics Committee, we conducted a survey between January and February 2011 in a nationally representative sample of 55 HIV treatment facilities (14 ATCs and 41 MUs) out of the 145 functioning at the time of the study period. We used a two-stage cluster sampling method to select the sample. The clusters consisted of the 12 following study regions: the cities of Yaoundé and Douala and the 10 administrative regions [Centre (excluding Yaoundé), Littoral (excluding Douala), Adamawa, East, Far North, North, North West, West, South and South West]. Facilities were selected from each region. The number of facilities selected in each region was equal to the sample size (55 HIV treatment facilities) multiplied by the percentage of the country's facilities functioning in the region. Each facility was then randomly selected with a probability proportional to its size (i.e. the number of HIV-infected patients in care in the facility). Finally, in each selected facility, we included PLWHA initiating ART during the month of October during the period 2007 -10; October was the month with the highest enrolment figures.
The medical records of all PLWHA .15 years of age who initiated ART in the month of October during the years 2007, 2008, 2009 and 2010 were used to gather sociodemographic, clinical and biological data. When the medical records were missing, we retrieved data from pharmacy registers or any other available files. Data were collected with a standardized questionnaire by trained abstractors, who were supervised by medical staff and statisticians of the National Institute of Statistics of Cameroon. The characteristics of the HIV treatment facilities participating in the survey were collected during interviews with site staff. In addition, data collected through population-based household interviews during the Cameroon national demographic and health survey (DHS; 2004) were used to construct regional-level variables (i.e. HIV prevalence, HIV/AIDS knowledge, attitudes and behaviours). 32 DHSs are nationally representative household surveys that provide data for a wide range of monitoring and impact evaluation indicators in the areas of population, health and nutrition. In Cameroon, the 2004 DHS included about 15000 individuals aged 15 -59 years and was conducted by the Cameroonian national institute of statistics with the collaboration of the ministry of public health. 33 
Data collection
We collected the following individual-level variables: gender, age at ART initiation, locality of residence, road distance to the closest HIV treatment facility, living area (urban/rural), last CD4 count before ART initiation, date of last CD4 count before ART initiation, date of ART initiation and WHO clinical stage at ART initiation.
At the facility level, we collected (i) site characteristics: whether the facility was an ATC or an MU, the number of beds in the facility and the availability of a CD4 cell counter (on site/off site); (ii) programme characteristics: research of missed visits (none, ART only or both ART and pre-ART), individual psychosocial support, voluntary counselling and testing (VCT), tuberculosis (TB) treatment, prevention of mother-to-child transmission (PMTCT), HIV awareness activities (on site/off site) and number of PLWHA associations affiliated with the facility; and (iii) programme burden data: number of providers (doctors, nurses, social workers and community health workers) and cumulative number of patients in care.
Regional-level variables included HIV prevalence rates and percentages of respondents (i) with comprehensive knowledge of HIV/AIDS; (ii) willing to take care of AIDS patients; (iii) knowing that condom use prevents HIV transmission; (iv) knowing that having only one uninfected faithful sexual partner prevents HIV transmission; (v) knowing that both condom use and having only one uninfected faithful sexual partner prevents HIV transmission; and (vi) having never been tested for HIV. In the DHS methodology, respondents were considered having comprehensive knowledge about HIV/AIDS if they (i) knew that consistent use of condoms during sexual intercourse and having only one uninfected faithful sexual partner can reduce the chance of getting HIV; (ii) knew that a healthy looking person can have HIV; and (iii) rejected misconceptions that AIDS can be transmitted by mosquito bites and/or supernatural means. 34 In the sensitivity analyses, we repeated the analysis using CD4 ≤50 cells/mm 3 as the criterion for late ART initiation.
Definition of late ART initiation
Statistical analysis
We used x 2 tests (for categorical variables) and median tests (for continuous variables) to compare differences in sociodemographic and clinical characteristics according to the year of ART initiation.
We explored individual-, facility-and regional-level explanatory variables (factors) associated with late ART initiation (CD4 ≤100 cells/mm 3 ) by using multilevel logistic regression models. To decide upon the number of levels to incorporate in the model, we performed an analysis of variance. We found that the between-facility variance (level 2) was Late antiretroviral therapy initiation in Cameroon significantly different from zero while the between-region variance (level 3) was zero in the empty model. We thus conducted a two-level regression analysis, with individuals (level 1) nested within facilities (level 2); this model takes into account the correlation in the outcome between individuals within each facility-level unit. 35 -38 The effects of regional (level 3) variables on the outcome variable were estimated within the two-level hierarchical model by assigning the same level 3 information to each patient living in the corresponding region. 39, 40 Continuous variables were categorized into tertiles or quartiles according to their distribution observed in the study. When independent variables had missing data, we added an additional category for the missing values and tested the effect of missing data on the outcome variable.
All factors with P values ≤0.20 in the bivariate regression analyses were included in the multivariate analyses. Interactions between variables were tested. Multicollinearity was assessed by calculating Cramer's V correlation coefficients. Two variables were considered collinear if the correlation coefficient was .0.70. 41 In this case, the least significant variable (with the largest P value) of the collinear variables was removed from the multivariate analysis. We used the 'xtmelogit' command of Stata 11.0 software to perform backward stepwise selection procedures, retaining in the final models all factors with P values ≤0.05. 42 The goodness of fit of the model was assessed by using the Hosmer-Lemeshow test. 43 
Results
Baseline characteristics
Regional HIV prevalence rates in Cameroon, the location of HIV treatment facilities participating in the survey and the number of PLWHA included in each locality are shown in Figure 1 . We collected data on 4935 PLWHA (.15 years of age) who initiated ART in the month of October during the period 2007 -10, in 55 HIV treatment facilities (Table 1 
Factors associated with late ART initiation
The distribution of CD4 cell counts at ART initiation among PLWHA initiating ART during the period 2007 -10 is shown in Figure 2 . Around 36% of PLWHA initiated ART with CD4 ≤100 cells/mm 3 . The multivariate analysis included 4154 PLWHA (corresponding to those with available baseline CD4 cell counts) nested in 47 HIV treatment facilities located in 12 study regions; 8 out of the 55 HIV treatment facilities were excluded from the analysis because they only had patients without record of CD4 counts before ART initiation.
In bivariate analysis, individual-level factors associated with higher odds of late ART initiation included male versus female gender. Being younger than age 30 or older than age 45 was associated with lower odds of late ART initiation (Table 2) .
Facility-level factors associated with higher odds of late ART initiation were enrolment in an ATC versus an MU, no PMTCT programme, .3 doctors on site, .199 hospital beds, .1700 ART patients in care (cumulative number), ≤10 nurses per 1000 ART patients and ≤20 healthcare workers (doctors and nurses) per 1000 ART patients (Table 3) . No regional-level factors were significantly associated with late ART initiation ( Table 4) .
We successively estimated two models in multivariate analyses. The first included individual-level factors only (level 1 model), while the second included individual-, facility-and regional-level factors (full model). We found an interaction between age and gender (P ¼ 0.043). In the level 1 model, after backward selection, we found that being a male younger than 45 years versus being a female younger than 45 years, living in an urban area versus a rural area and initiating ART in 2007-09 versus later were associated with higher odds of late ART initiation (Table 5 ). In the full model, individual-level factors independently associated with late ART initiation had ORs very close to those estimated in the level 1 model. In addition, late ART initiation was more likely in ATCs than in MUs and also in facilities without a PMTCT programme. Enrolment in a region where the proportion of individuals with comprehensive knowledge of HIV/AIDS was .22% was associated with lower odds of late ART initiation. As shown in Figure S1 (available as Supplementary data at JAC Online), the between-facility variance in the log odds of late ART initiation estimated before controlling for explanatory variables (see Figure S1a , available as Supplementary data at JAC Online) was totally explained by the individual-, facility-and regional-level factors considered in the analyses (see Figure S1b , available as Supplementary data at JAC Online). 0  50  100  150  200  250  300  350  400  450  500  550  600  650  700  750  800  850  900  950  1000  1050  1100  1150  1200 CD4 count (cells/mm 3 )
Number of PLWHA Figure 2 . Distribution of CD4 cell counts at ART initiation in Cameroon, 2007 -10 (n¼4154). Road distance between the HIV treatment facility and patient's home was measured (in km) using Google maps tools (http://maps.google.com). 
Late antiretroviral therapy initiation in Cameroon
When late ART initiation was defined by a baseline CD4 cell count of ≤50/mm 3 , the same factors were associated with late ART initiation, except for the year of ART initiation (see the right-hand column in Table 5 ).
Discussion
This study is the first to investigate the simultaneous effect of individual-, facility-and regional-level factors associated with late ART initiation, defined as CD4 ≤100 cells/mm 3 . We found that, in Cameroon, being a male younger than 45 years rather than a female younger than 45 years, initiating ART in 2007 -09 rather than later, being enrolled in an ATC versus an MU, being treated in a facility without a PMTCT programme and living in a region with low comprehensive knowledge of HIV/AIDS were associated with higher odds of late ART initiation. The strengths of this study include the random sampling method, the large number of patients included and the multilevel approach. Although we were able to control for a wider range of factors than in previous studies, we could not investigate the association between late ART initiation and other individual factors, such as marital and pregnancy status, household income, level of education, substance use or the point of entry into HIV care (PMTCT, VCT or TB), because these data were missing from medical records or not available. In addition, the DHS data used as a source of regional-level data were collected before the study period. The use of more recent DHS data might have given different results.
Other studies in sub-Saharan Africa have shown that male gender and/or younger age were associated with late ART initiation. 25 -28,44 -48 Later ART initiation among young males could be due to longer delays from ART eligibility to ART initiation and/or to later presentation for HIV care. A recent study in Cameroon showed that young males eligible for ART were less likely to begin treatment. 49 However, only a small minority of patients eligible for ART (7%) were not treated. This suggests that late ART initiation among young males in Cameroon is due to late presentation rather than to longer delays from ART eligibility to ART initiation. PLWHA who began ART in 2010 were less likely to be treated late than those who began ART in the period 2007 -09. This encouraging trend, which has also been found in other subSaharan African countries, 7, 27 probably reflects recent changes in national guidelines on ART eligibility. In August 2010, Cameroon adopted the revised 2010 WHO guidelines recommending ART initiation at CD4 ≤350 cells/mm 3 (compared with ≤200 cells/mm 3 previously). 29, 30 Thus, the CD4 count at ART initiation might have risen because HIV-infected patients who were already in care and who had CD4 cell counts between 200 and 350/mm 3 became eligible for ART under the new guidelines. Another explanation for the rising CD4 count at ART initiation could be a result of increasing efforts to scale-up ART in Cameroon since 2007, the year when ART became free. The sickest pool of patients (i.e. the ones diagnosed before 2007 and waiting for free ART) could have been treated at the beginning of free drug availability. Nevertheless, when late treatment was defined as ART initiation at CD4 ≤50 cells/mm 3 , the year of ART initiation was no longer significantly associated with late treatment. Thus, despite the new guidelines on ART, some HIV-infected individuals still present very late.
At the facility level, we found that PLWHA initiating ART in central-and regional-level hospitals (ATCs) had higher odds of initiating ART late than those enrolled in district hospitals (MUs). Other studies in sub-Saharan Africa showed that PLWHA initiating ART in urban centres had lower CD4 counts at ART initiation than those initiating ART in rural centres. 7, 27, 50 The proximity of district hospitals could explain earlier access to treatment after HIV diagnosis and, thus, earlier ART initiation. A more 'mature' HIV epidemic in large cities than in small localities could also be a reason for later ART initiation among patients attending ATCs. 51 Other possible explanations are that severely immunocompromised patients diagnosed in MUs are referred to ATCs and/or ATCs attract more patients with advanced HIV infection than MUs, because ATCs are associated with large hospitals where HIV infection could be diagnosed during inpatient management. However, limited data exist on the referral pattern of patients initiating ART in medical records; therefore, we could not study its impact on the timing of ART initiation. These findings show that decentralization of HIV care has allowed some patients to access and initiate treatment earlier: the ones enrolled in care at the district level. However, for the decentralization of HIV care to be completely successful in Cameroon, 21 some efforts now have to be made to understand and solve the issue of later ART initiation of patients enrolled in central-and regional-level hospitals.
We also found that presentation to facilities where PMTCT programmes are available was associated with earlier ART initiation. As shown in other studies, 7, 27 this result suggests that stronger linkage with PMTCT programmes may enable earlier ART initiation. VCT and TB treatment programmes are also critical entry points for HIV care; 52 -54 however, as these programmes are available in almost all HIV treatment centres in Cameroon, 20 we could not evaluate their impact on the timing of ART initiation. Additional individual data, such as the pregnancy status of females at ART initiation and the point of entry into HIV care (PMTCT, VCT or TB), are needed to further investigate the impact of PMTCT, TB and VCT programmes on the timing of ART initiation.
At the regional level, we found that living in a region where comprehensive knowledge of HIV/AIDS was high was associated with not initiating ART late. This result, which was also found in other sub-Saharan African countries, 7 demonstrates that HIV/AIDS education programmes at the population level can increase awareness and knowledge of serostatus in ways that may have an impact on population health.
In conclusion, the scale-up of free ART has drastically improved access to treatment in developing countries, 55 but too many patients continue to initiate ART late in the infection. Our study shows that risk factors associated with late ART initiation in Cameroon are multidimensional and operate at the individual, facility and regional levels, indicating a need for multilevel interventions to reduce late ART initiation. Such interventions should include (i) the promotion of HIV testing among young males; (ii) the strengthening of existing integrated PMTCT, VCT and TB programmes in HIV facility centres, to improve HIV testing and linkage to care; and (iii) increasing the level of knowledge about HIV/AIDS in the general population.
